Global Health Community Says The U.S. Is Picking Big Business Over Patients Again
The global health community has once again found itself in a familiar position: fighting the U.S. on a policy previously seen as a no-brainer. They say the U.S. aggressively sought to water down language that gives governments the option to allow generic versions of patented TB drugs through "compulsory licensing" in the interest of public health and access. Advocacy groups say it gives patients better treatment access by making medicine more affordable, but the pharmaceutical industry argues it breaks patent law and kills innovation. For instance, Colombia's attempt to use such compulsory licensing for generic medications saw pushback from the U.S. trade representative this summer, according to STAT. "According to recent reports, the United States government's funding for global TB [research and development] makes up almost 60 percent of the world's investment," a U.S. representative said during a recent U.N. hearing to discuss the declaration.Behind the Cover: The Big Business of Being Gwyneth Paltrow
referring to Jake Silverstein, editor in chief: "Gwyneth Paltrow has been on many magazine covers, of course, so we wanted an image that showed her in a new light. Amanda Demme's portrait is done in cool tones, clearly distinct from the more warm and earthy tones typical of how Paltrow usually appears, and perfectly in keeping with the theme of Taffy Brodesser-Akner's article: how she has turned wellness into a very big business."Read the cover story "The Big Business of Being Gwyneth Paltrow."collected by :Dicson Walt
إرسال تعليق